Antibody-cytokine fusion proteins: innovative weapons in the war against cancer.

Autor: Dela Cruz, J. S., Huang, T. H., Penichet, M. L., Morrison, S. L.

Publikováno v: Clinical & Experimental Medicine; Sep2004, Vol. 4 Issue 2, p57-64, 8p, 1 Diagram

LogIO: An Adaptive Gamification Learning Approach on Digital Logic Gates

Autor: Torio, JO, Bigueras, R T, Maligat, D E, Arispe, M A, Dela Cruz, J S

Publikováno v: IOP Conference Series: Materials Science and Engineering; April 2020, Vol. 803 Issue: 1 p012008-012008, 1p

Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3).

Autor: Peng LS; Department of Microbiology, Immunology and Molecular Genetics and the Molecular Biology Institute, University of California, Los Angeles, CA 90095-1489, USA., Penichet ML, Dela Cruz JS, Sampogna SL, Morrison SL

Publikováno v: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2001 Sep; Vol. 21 (9), pp. 709-20.

A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors.

Autor: Penichet ML; Department of Microbiology and Molecular Genetics, and the Molecular Biology Institute, University of Califorina, Los Angeles, 405 Hilgard Avenue, Los Angeles, CA 90095-1489, USA., Dela Cruz JS, Shin SU, Morrison SL

Publikováno v: Human antibodies [Hum Antibodies] 2001; Vol. 10 (1), pp. 43-9.